| What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies |
12 |
| Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study |
10 |
| Hemostasis based on a novel 'two-path unifying theory' and classification of hemostatic disorders |
6 |
| Thrombin generation estimates the anticoagulation effect of direct oral anticoagulants with significant interindividual variability observed |
6 |
| Complement-coagulation connections |
6 |
| Intracranial hemorrhage in congenital bleeding disorders |
5 |
| Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells |
5 |
| Ibrutinib-related bleeding: pathogenesis, clinical implications and management |
5 |
| Congenital hypofibrinogenemia in pregnancy: a report of 11 cases |
5 |
| Thromboelastography in the management of snakebite-induced coagulopathy: a case series and literature review |
5 |
| Thromboelastographic study of the snakebite-related coagulopathy in Djibouti |
5 |
| The predictive value of stress hyperglycemia on thrombus burden in nondiabetic patients with ST-segment elevation myocardial infarction |
4 |
| Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus |
4 |
| Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis |
4 |
| Risk factors associated with intraventricular hemorrhage in extremely premature neonates |
4 |
| Newly developed left ventricular apical thrombus under dabigatran treatment |
4 |
| Synergistic inhibitory effect of capsaicin and dihydrocapsaicin on in-vitro platelet aggregation and thromboxane formation |
3 |
| Prediction of thromboembolic complications after liver resection for cholangiocarcinoma: is there a place for thromboelastometry? |
3 |
| Predicting mortality in patients with disseminated intravascular coagulation after cardiopulmonary bypass surgery by utilizing two scoring systems |
3 |
| Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients |
3 |
| Probable drug-drug interaction between dabigatran and quinidine resulting in thrombin time rebound despite multiple idarucizumab doses |
3 |
| Disseminated intravascular coagulation: is it fact or fancy? |
3 |
| An ex-vivo model of shear-rate-based activation of blood coagulation |
3 |
| A bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice |
3 |
| Thrombogenesis and thrombotic disorders based on 'two-path unifying theory of hemostasis': philosophical, physiological, and phenotypical interpretation |
3 |
| Thromboelastometric prediction of mortality using the kinetics of clot growth in critically ill septic patients |
3 |
| Accelerating recovery from acute hemarthrosis in patients with hemophilia: the role of joint aspiration |
3 |
| Rivaroxaban and the EINSTEIN clinical trial programme |
2 |
| Management of dabigatran after overdosage: two case reports and suggestions for monitoring |
2 |
| Prenatal thrombosis of renal veins and the inferior vena cava in a newborn with double heterozygosity for the factor V Leiden and prothrombin gene G20210A mutations: a case report |
2 |
| Anticoagulant activity of krait, coral snake, and cobra neurotoxic venoms with diverse proteomes are inhibited by carbon monoxide |
2 |
| Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent among young Japanese women |
2 |
| Venous thromboembolism risk associated with ABO, F11 and FGG loci |
2 |
| Thromboelastographic analysis of haemostasis in preeclamptic and normotensive pregnant women |
2 |
| Prevalence of factor VIII inhibitors among Afghan patients with hemophilia A: a first report |
2 |
| Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia |
2 |
| Thrombin potential and traditional coagulation assay: are they useful in exploring recurrent pregnancy loss risk? |
2 |
| Association of hyperglycemia, systolic and diastolic hypertension, and hyperthermia relative to baseline in the acute phase of stroke with poor outcome after intravenous thrombolysis |
2 |
| Prolonged activated partial thromboplastin time due to plasma prekallikrein deficiency: a case study and literature review on its clinical significance |
2 |
| Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding: a pilot study |
2 |
| Immunopathological response to severe injury: platelet activation and the Th-17 immune response |
2 |
| Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female |
2 |
| Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia |
2 |
| Diminished coagulation capacity assessed by calibrated automated thrombography during acute Puumala hantavirus infection |
2 |
| An intronic mutation c.6430-3C > G in the F8 gene causes splicing efficiency and premature termination in hemophilia A |
2 |
| Role of perfusion defects at follow-up lung scan in predicting recurrences after a first episode of symptomatic pulmonary embolism: a retrospective analysis |
2 |
| Effects of malignancy on blood coagulation in septic intensive care patients |
2 |
| Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment |
2 |
| Thromboelastometry in critically ill patients with disseminated intravascular coagulation |
2 |
| Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis |
2 |
